AllerGen NCE Inc. (AllerGen), the Allergy, Genes and Environment Network, is a national research network funded by Industry Canada through the Networks of Centres of Excellence (NCE) Program.

AllerGen was established in response to the fact that one in three Canadians is living with allergic disease. Since inception, AllerGen has been supporting excellence in research and fostering commercialization, social innovation and knowledge mobilization that will enable Canadians to better prevent, treat and manage allergic diseases and asthma. This national network is made up of leading Canadian allergy, asthma, anaphylaxis and immune diseases experts with research expertise across the spectrum of biomedical, social and natural sciences. These researchers are working in trans-disciplinary and multi-sectoral teams, with national and international collaborators and stakeholder and research partner organizations. They are addressing gaps in knowledge and seizing new opportunities in diagnostics, therapeutics, health care, public health, ethics, policy, clinical care and patient education. AllerGen is also training the next generation of researchers, innovators and clinician-scientists, while collaboratively working to reduce the morbidity, mortality and socio-economic impacts of allergy, asthma, anaphylaxis and related immune diseases.